Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9928075 | 1.00 | CASR (0.33) | CASRHTT | |
| SCHEMBL9928089 | 0.96 | CASR (0.32) | CASR | |
| SCHEMBL9928081 | 0.96 | CASR (0.32) | CASR | |
| SCHEMBL9928082 | 0.96 | CASR (0.33) | CASRHTT | |
| SCHEMBL9928087 | 0.96 | CASR (0.33) | CASRHTT | |
| SCHEMBL9928080 | 0.94 | HTT (0.32) | CASRHTT | |
| SCHEMBL9928076 | 0.94 | HTT (0.32) | CASRHTT | |
| SCHEMBL9928083 | 0.94 | CASR (0.35) | CASR | |
| SCHEMBL9928090 | 0.94 | CASR (0.35) | CASR | |
| SCHEMBL9928085 | 0.94 | CASR (0.35) | CASR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9944534-B2 | Reducing aluminosilicate scale in the Bayer process | ECOLAB USA INC. (US) | 2018-04-17 | — | — | US | disclosed |
| US-9944534-B2 | Reducing aluminosilicate scale in the Bayer process | ECOLAB USA INC. (US) | 2018-04-17 | — | — | US | disclosed |
| US-20170050861-A1 | Reducing Aluminosilicate Scale in the Bayer Process | NALCO COMPANY (US) | 2017-02-23 | — | — | US | disclosed |
| US-20170050861-A1 | Reducing Aluminosilicate Scale in the Bayer Process | NALCO COMPANY (US) | 2017-02-23 | — | — | US | disclosed |
| US-9487408-B2 | Reducing aluminosilicate scale in the bayer process | NALCO COMPANY (US) | 2016-11-08 | — | — | US | disclosed |
| US-9487408-B2 | Reducing aluminosilicate scale in the bayer process | NALCO COMPANY (US) | 2016-11-08 | — | — | US | disclosed |
| US-20120148462-A1 | REDUCING ALUMINOSILICATE SCALE IN THE BAYER PROCESS | ECOLAB USA INC. | 2012-06-14 | — | — | US | disclosed |
| US-20120148462-A1 | REDUCING ALUMINOSILICATE SCALE IN THE BAYER PROCESS | ECOLAB USA INC. | 2012-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170050861-A1 | Reducing Aluminosilicate Scale in the Bayer Process | DSP, SOST, SORD | CASR 612/4885HTT 2952/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.